|
Cholesterol Drug Not Effective In Study
|
A clinical trial of a widely used cholesterol drug has raised questions both about the medicine’s effectiveness and about the behavior of the pharmaceutical companies that conducted the study, cardiologists said Monday. ... |
Source Blog Post
|
More items about Florida Personal Injury Lawyer similar to this Blog Post
|
|
This week€™s edition of Washington€™s €œLegal Times€ contains an article on the DC Madam trial, which starts this week. By all accounts, the trial ought to be great entertainment - so long as we forget that this woman is being persecuted ... |
|
PercipEnz Technologies, Inc., creators of the most widely adopted clinical trials management software system among cancer clinical research centers, has received notice that their flagship product, Oncore, has been awarded the coveted caBIG Bronze C... |
|
PercipEnz Technologies, Inc., creators of the most widely adopted clinical trials management software system among cancer clinical research centers, has received notice that their flagship product, Oncore, has been awarded the coveted caBIG Bronze C... |
|
PercipEnz Technologies, Inc., creators of the most widely adopted clinical trials management software system among cancer clinical research centers, has received notice that their flagship product, Oncore, has been awarded the coveted caBIG(tm) Bron... |
|
The US Food and Drug Administration (FDA) has identified 25 drugs and biologic products that will be expected to turn in safety plans called Risk Evaluation and Mitigation Strategy (REMS), the FDA said in a recently published Federal ... |
|
Younger ER patients with heart attack symptoms should be asked if they€™ve recently used cocaine, which can cause similar chest pain, the American Heart Association warns doctors. For these patients, honesty can be a matter of life or ... |
|
A rigorous study involving the heart surgery drug Trasylol is likely to seal the drug€™s fate, as researchers are left with little doubt of the greater likelihood of death in patients given the anti-bleeding medication. ... |
|
Gentech notified healthcare professionals of revisions to the prescribing information on the drug Rituxan after a woman who was treated with it died from a brain infection, according to the Food and Drug Administration (FDA). ... |
|
|
|